Back to Market Feed

NEUPOGEN 300 MCG/0.5 ML SYR

$651.0520per ML

Strength

300 ug/.5mL

Manufacturer

NDC

55513092491

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

11/19/2025

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

10/2/2000

Pharmacological Classes

Granulocyte Colony-Stimulating Factor

Increased Myeloid Cell Production

Leukocyte Growth Factor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.0%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

+0.3%

Generic Alternatives

Save up to 53%

1 alternative • Same active ingredient

NEUPOGEN 300 MCG/ML VIAL

55513053010•Amgen Inc.

Related Drugs

Same classification

NEULASTA 6 MG/0.6 ML SYRINGE

55513019001•Amgen Inc.